Literature DB >> 19538143

Formation mechanism of insulin fibrils and structural aspects of the insulin fibrillation process.

M Groenning1, S Frokjaer, B Vestergaard.   

Abstract

The therapeutic importance of gaining a thorough knowledge on insulin fibrillation in relation to type I diabetes has lead to six decades of studies focusing on its formation kinetics and structural characteristics. Insulin fibrils feature characteristics common to amyloid fibrils such as an elongated morphology, characteristic cross-beta diffraction pattern, Thioflavin T fluorescence, and Congo Red birefringence. A full understanding of the fibrillation process requires structural elucidation of every species and determination of the kinetics of interconversion between species on the reaction pathway. Therefore, describing the underlying mechanism is complicated and different mechanisms have been proposed. In the recent years increased knowledge has been obtained on the importance of prefibrillar oligomeric species present during the process. A solution structure of such a species and also low-resolution structures of mature insulin fibrils have been obtained as well as high-resolution structures of two insulin hexa-peptide segments forming cross-beta sheet structures. However, it still remains to be elucidated whether these cross-beta structures corresponds to the structure in the fibril formed from the full-length protein. Different morphologies of insulin fibrils are observed depending on the arrangement of the protofilament, and even circular amyloids and spherulites composed of a core with many fibrils extending from it have been observed. This review will mainly focus on the structure of the species present during the insulin fibrillation process such as the partially unfolded monomeric intermediate, prefibrillar oligomeric species, and the insulin fibrils. Furthermore, it will address the formation mechanism and potential inhibition of the fibrillation process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538143     DOI: 10.2174/138920309789352038

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  23 in total

1.  Intrinsic fibrillation of fast-acting insulin analogs.

Authors:  R Jeremy Woods; Javier Alarcón; Elaine McVey; Ronald J Pettis
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

2.  Stepwise organization of the β-structure identifies key regions essential for the propagation and cytotoxicity of insulin amyloid fibrils.

Authors:  Eri Chatani; Hiroshi Imamura; Naoki Yamamoto; Minoru Kato
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

3.  Controlling the aggregation and rate of release in order to improve insulin formulation: molecular dynamics study of full-length insulin amyloid oligomer models.

Authors:  Workalemahu Mikre Berhanu; Artëm E Masunov
Journal:  J Mol Model       Date:  2011-06-15       Impact factor: 1.810

4.  ICA512 RESP18 homology domain is a protein-condensing factor and insulin fibrillation inhibitor.

Authors:  Pamela L Toledo; Juha M Torkko; Andreas Müller; Carolin Wegbrod; Anke Sönmez; Michele Solimena; Mario R Ermácora
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

5.  Injection of insulin amyloid fibrils in the hippocampus of male Wistar rats: report on memory impairment and formation of amyloid plaques.

Authors:  Raheleh Kheirbakhsh; Maryam Chinisaz; Saeed Khodayari; Saeid Amanpour; Ahmad-Reza Dehpour; Ahad Muhammadnejad; Bagher Larijani; Azadeh Ebrahim-Habibi
Journal:  Neurol Sci       Date:  2015-03-19       Impact factor: 3.307

6.  Exploration of Insulin Amyloid Polymorphism Using Raman Spectroscopy and Imaging.

Authors:  Mika Ishigaki; Kana Morimoto; Eri Chatani; Yukihiro Ozaki
Journal:  Biophys J       Date:  2020-05-04       Impact factor: 4.033

Review 7.  Recent progress on understanding the mechanisms of amyloid nucleation.

Authors:  Eri Chatani; Naoki Yamamoto
Journal:  Biophys Rev       Date:  2017-12-06

8.  Modulating Insulin Fibrillation Using Engineered B-Chains with Mutated C-Termini.

Authors:  Mohsen Akbarian; Reza Yousefi; Ali Akbar Moosavi-Movahedi; Atta Ahmad; Vladimir N Uversky
Journal:  Biophys J       Date:  2019-09-23       Impact factor: 4.033

9.  The molecular chaperone alpha-crystallin as an excipient in an insulin formulation.

Authors:  Tue Rasmussen; Ruedeeporn Tantipolphan; Marco van de Weert; Wim Jiskoot
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

10.  Inhibition of Insulin Amyloid Fibrillation by a Novel Amphipathic Heptapeptide: MECHANISTIC DETAILS STUDIED BY SPECTROSCOPY IN COMBINATION WITH MICROSCOPY.

Authors:  Bhisma N Ratha; Anirban Ghosh; Jeffrey R Brender; Nilanjan Gayen; Humaira Ilyas; Chilukoti Neeraja; Kali P Das; Atin K Mandal; Anirban Bhunia
Journal:  J Biol Chem       Date:  2016-09-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.